Latest
Big pharma
Biotechnology
CRISPR
Generics
Unified Patent Court
Regions
Americas
Europe
Asia
Asia-Pacific
Careers
Events
Conferences
Conference Videos
Webinars
Directory
Magazines
About
Contact
Newsletter
Login
Subscribe
Home
About
Contact
Newsletter
Login
Request Trial
Home
Latest News & Features
Latest News & Features
Reset all filters
Article Type
Any type
Features
Channels & Sectors
Any channel
Africa
Americas
Asia
Asia-Pacific
Big Pharma
Biotechnology
CRISPR
Europe
Explainer
Generics
Genetics
Medtech
Patents
Plant Varieties
Regions
Sectors
Unified Patent Court
Geography
Any geography
Africa
Americas
Antigua and Barbuda
Asia
Australia
Austria
Belarus
Belgium
Brazil
Brunei
Canada
Caribbean
Chile
China
Colombia
Costa Rica
Denmark
EPO
EU
Ethiopia
Eurasia
Europe
France
Germany
Global
India
Indonesia
International
Ireland
Israel
Italy
Jamaica
Japan
Kazakhstan
Kenya
Malaysia
Mexico
Netherlands
Nigeria
Norway
Peru
Poland
Russia
Saint Vincent and the Grenadines
Singapore
South Africa
South Korea
Spain
Sweden
Switzerland
Thailand
UK
US
Ukraine
United Kingdom
United States
Vietnam
Company
Any company
ARIPO
10x Genomics
3M
5AM Ventures
ACI
ALLEN & OVERY LLP
AMGEN INC.
ARNOLD & PORTER LLP
ARNOLD & PORTER
AbbVie
Abbott
Abe & Partners
Abingworth
Actavis
Adalvo
Adamas Pharmaceuticals
Adams & Adams
Akebia Therapeutics
Akerman
Alexion Pharmaceuticals
Alibaba
AliveCor
Allen & Overy
Allergan
Alnylam Pharmaceuticals
Alston & Bird
Alta Innovations
Alvotech
American Bar Association
Anand and Anand
Apotex
Apple
Appleyard Lees
Arch Venture Partners
Arent Fox
Ariosa Diagnostics
Arthrex
Aslan
Association of the British Pharmaceutical Industry
AstraZeneca
Atlas Venture
Axonics
BIO
BMS
BSH Hausgeräte
Baker Botts
Banner Witcoff
Barnes & Thornburg
Bayer
Becerril
Bereskin & Parr
Berkeley
BioNTech
Biogen
Birch Stewart Kolasch & Birch
Bird & Bird
Boehringer Ingelheim
Brazilian Patent and Trademark Office
Brinks Gilson & Lione
Bristol - Myers Squibb
Bristows
Broad Institute
C5
CASIS
CCPIT
CMS
Capstan Therapeutics
Carpmaels & Ransford
Casimir Jones
Celgene
Cella
Cellect
Cellular Dynamics International
Clark Modet & Co
Clarke Modet & Co
Coca & Becerril
Crowell & Moring
DISH
DLA Piper
Daniel Law
Daniel Legal & IP Strategy
Defra
Dennemeyer
DexCom
Di Blasi
Domain Associates
Dow Agrosciences
Dr Reddy
Drugs for Neglected Diseases
Duane Morris
EBD Group
EIP
EPO
ERS Genomics
Eagle IP
Edwards Lifesciences
Electrolux
Eli Lilly
Elkington + Fife
Endeavour Vision
Ericsson
European Medicines Agency
European Patent Office
European parliament
F Prime Capital Partners
FOLEY & LARDNER LLP
Farabow
Fibria Celulose
Finnegan
Fish & Richardson
Fitzpatrick
Flagship Pioneering
Flynn Pharma
Foga Daley
Foley & Lardner
Food and Drug Administration
Founders Fund
Francis Crick Institute
Frazier Healthcare Partners
GE Ventures
GQ Life Sciences
GSK
Garrett & Dunner
Gerber & Eisenberg
Gilead
Globus Medical
Gomez Vega & Uhthoff
Grünecker
Gurnet Point Capital
HGF
HOGAN LOVELLS INTERNATIONAL LLP
Harness IP
Harper & Scinto
Harvard
Haynes and Boone
Henderson
Herbert Smith Freehills
Hiller
Hogan Lovells
Hologic
Horizon Europe
Humira
IBM
IMPI
INES
IPOS International
Illumina
International Trade Commission
Inventa International
Inventa
JA Kemp
Janssen Biotech
Johnson & Johnson
K&S Partners
KIRKLAND & ELLIS LLP
KIRKLAND & ELLIS
KNect365
Kasznar Leonardos
Keesha Fleming Lake
Keker
Kleiner Perkins Caufield & Byers
Kymab
LSX
Last Mile Health
Life Technologies
LifeBank
Lundbeck
Lusheng
MIT
MSD
Marks & Clerk
Masimo
McKool Smith
MedImmune
Medtronic
Merchant & Gould
Merck KGaA
Merck
Merial
Meril Life Sciences
Mewburn Ellis
Microsoft
Minerva
Mintz
Moderna
Monsanto
Morgan Lewis
Morrison & Foerster
Mylan
Myriad Genetics
Médecins Sans Frontières
NASA
NHS
NanoString Technologies
Natco Pharma
Natera
National Center for Scientific Research
National Health Service England
Neal
Neurim
Neurimmune
Novartis
Novavax
Novo Nordisk
Olivares
PFIZER INC.
PHRU
Palo Santo Ventures
Papula-Nevinpat
Parente & Associados
Parker Poe
PatSnap
Pearce IP
Penningtons Manches
Pieris Pharmaceuticals
Pinsent Masons
Potter Clarkson
Powell Gilbert
Promega
Ranbaxy
Ravgen
Regeneron
Roche
Ropes & Gray
Rospatent
Rouse
Royalty Pharma
SAMRC
Samsung Bioepis
Samsung
Sangamo Therapeutics
Sanofi
Saul Ewing Arnstein & Lehr
Sayenko Kharenko
Servier
Shire
SiBio
Sideman & Bancroft
Siemens
Simões Propriedade Intelectual
Smart & Biggar/Fetherstonhaugh
Sofinnova Partners
Sterne, Kessler, Goldstein & Fox
Supernus Pharmaceuticals
SurgiSil
THOMSON REUTERS CORPORATION
Takeda
Taylor Wessing
Teva
Tokyo Institute of Technology
Trilobio
Troutman Pepper
UCB
UK Intellectual Property Office
Uhthoff
Unified Patent Court
United Nations
University of Birmingham
University of California
University of Dundee
University of Glasgow
University of Harvard
University of Oxford
University of Tübingen
Van Nest & Peters
Venrock
Ventria bioscience
Vizgen
Vossius & Partner
WARNER-LAMBERT COMPANY
WHO
Wake Forest Institute for Regenerative Medicine
WilmerHale
Wuhan Healthgen Biotechnology
Ximedica
Yumanity Therapeutics
aTyr Pharma
uBiome
Search
Refine Search
Americas
Stricter examination requirements in Canada
Two pharmaceutical cases highlight recent developments in Canadian patent law relating to duty of candour during patent prosecution and patent claim construction, says Katie Wang.
1 May 2010
Previous page
82
83
84
85
86
